What do Clinical Psychologists Do?
Clinical psychologists wear many hats. They help people deal with their problems, change their behavior, and adjust to life’s difficulties. Clinical psychologists work with those who need more long term and intensive help that a counseling psychologist can offer. Psychology degree programs can help those with an undergraduate degree in psychology broaden their focus.
Where do Clinical Psychologists Work?
Clinical psychologists work in a wide variety of settings. They typically work in mental health clinics, hospitals, counseling centers, prisons, and nursing homes. Their work in hospitals, nursing homes, and prisons help both the individual patient and their families deal with the changes that may be taking place in their lives. Clinical psychologists also help people admitted to hospitals for alcohol or drug problems, eating disorders, and who are experiencing other behavioral/mental health issues.
]]>
How do Clinical Psychologists Help?
A psychology doctorate program will help the student to learn how to deal with a variety of issues they will come across in their work. This may include, but is not limited to, death, anxiety, depression, divorce, addiction, eating disorders, and abusive relationships. Clinical psychologists are not allowed to prescribe drugs to their patients, but they do refer their patients to medical doctors if they feel it is necessary for their treatment. Most of what clinical psychologists do is try to sort out confusing thoughts and feelings that may be interfering with a person’s life.
What are Alternative Career Opportunities for a Clinical Psychologist?
Clinical psychologists who are more experienced may choose to alter their career path and work in a more alternative setting. One example is forensic psychology. Clinical psychologists evaluate the mental health of suspects, write legal reports in cases, and act as experts in criminal trials. They may also work as a consultant to social, educational, and welfare agencies by designing and implementing new mental health programs. These types of careers require experience in the field and completion of psychology degree programs.
A psychology doctorate program is the first step after receiving an undergraduate degree for those who want to become clinical psychologists. However, there are many aspects to consider before embarking on the education. While the work is extremely rewarding and fulfilling, it can also be extremely difficult at times. Clinical psychologists must be prepared to deal with other people’s problems without becoming emotionally invested, and they must be able to encounter frustrating and depressing situations on a daily basis. Despite these extreme conditions, many clinical psychologists find their work to be extremely rewarding and feel as though their psychology degree programs prepared them for this new career.
Benefits of Clinical Data Management
Life sciences and medical expertise worldwide have reached at a stage where every human gene and its functionalities are being researched. Currently the era is of systematic studies and disciplined collection of data from sample analysis and screening of various samples ranging from microbiological to human patients. Any clinical research needs a vast number of candidates and individuals, who can be studied, thus help create a database that can be statistically analyzed and data can be generated to come up with an accurate solution for the subject under test. Clinical data management along with the lines of biometric clinical research forms a strong foundation that enables CRO’s to obtain vital information, statistically analyze and identify human traits who are undergoing phase trials based on intrinsic and physical factors.
Clinical Data Management Studies is also called as CDMS, and as the name itself suggest the literal meaning of the term. Simply put, it means storage and maintaining data and records of patients.
CDMS is a system which helps to monitor health information and also the crucial financial details of patients under study. Thus it saves a lot of manual workload and become a single database which comprises of all the important details about the samples and subject that are under screening procedures. Biometrics data mining is the method of finding the patient’s data from the stored records, posing queries and extracting crucial information from the database to find a better and accurate results pertaining to the research undertaken. The terms biometrics was basically correlated with research as biometric clinical trials were based upon collection of large amount of statistical data which was collected during different phases of drug development for medical illnesses. There are numerous clinical research organizations that have initiated biometric clinical research services to provide a confined statistical analysis and evaluating the effectiveness of drugs/medical methods in line to be commercialized.
To summarize clinical data management shortens the time and energy required for carrying out elaborate clinical research process. The new protocols can be easily modified and included in the existing systems. CDMS along with biometrics data mining is rapidly gaining popularity in many organizations that undertake clinical research services.
With effective biometric clinical research and systematic approach during biometric clinical trials a CRO proudly gains an edge over its counterparts. India also has many centers providing biometric and clinical data management services to attract big pharma companies to invest in them.
Ethical Requirements: Clinical Research
“…the physician’s role in the physician patient relationship is different from the researcher’s role in the researcher-research subject relationship”
All physicians make use of the results of medical research in their clinical practice. To maintain their competence, physicians must keep up with the current research in their area of practice through Continuing Medical Education/ Continuing Professional Development programs, medical journals and interaction with knowledgeable colleagues. Even if they do not engage in research themselves, physicians must know how to interpret the results of research and apply them to their patients. Thus, a basic familiarity with research methods is essential for competent medical practice.
The best way to gain this familiarity is to take part in a research project, either as a medical student or following qualification. The most common method of research for practicing physicians is the clinical trial. Before a new drug can be approved by government mandated regulatory authorities, it must undergo extensive testing for safety and efficacy. The process begins with laboratory studies followed by testing on animals. If this proves promising, the four steps, or phases, of clinical research, are next.
The rapid increase in recent years in the number of ongoing trials has required finding and enrolling ever-larger numbers of patients to meet the statistical requirements of the trials. Those in charge of the trials, whether independent physicians or pharmaceutical companies, now rely on many other physicians, often in different countries, to enroll patients as research subjects. Although such participation in research is valuable experience for physicians, there are potential problems that must be recognized and avoided. In the first place, the physician’s role in the physician patient relationship is different from the researcher’s role in the researcher research subject relationship, even if the physician and the researcher are the same person. The physician’s primary responsibility is the health and well-being of the patient, whereas the researcher’s primary responsibility is the generation of knowledge, which may or may not contribute to the research subject’s health and well being. Thus, there is a potential for conflict between the two roles.
]]>
When this occurs, the physician role must take precedence over the researcher. Another potential problem in combining these two roles is conflict of interest. Medical research is a well-funded enterprise, and physicians are sometimes offered considerable rewards for participating. These can include cash payments for enrolling research subjects, equipment such as computers to transmit the research data, invitations to conferences to discuss the research findings, and co-authorship of publications on the results of the research. The physician’s interest in obtaining these benefits can sometimes conflict with the duty to provide the patient with the best available treatment. It can also conflict with the right of the patient to receive all the necessary information to make a fully informed decision whether or not to participate in a research study.
These potential problems can be overcome. The ethical values of the physician – compassion, competence, autonomy – apply to the medical researcher as well. So there is no inherent conflict between the two roles. As long as physicians understand and follow the basic rules of research ethics, they should have no difficulty participating in research as an integral component of their clinical practice.
The basic principles of research ethics are well established. It was not always so, however. Many prominent medical researchers in the 19th and 20th centuries conducted experiments on patients without their consent and with little if any concern for the patients well-being. Although there were some statements of research ethics dating from the early 20th century, they did not prevent physicians in Nazi Germany and elsewhere from performing research on subjects that clearly violated fundamental human rights.
Following World War Two, some of these physicians were tried and convicted by a special tribunal at Nuremberg, Germany. The basis of the judgment is known as the Nuremberg Code, which has served as one of the foundational documents of modern research ethics. Among the ten principles of this Code is the requirement of voluntary consent if a patient is to serve as a research subject.
The World Medical Association was established in 1947, the same year that the Nuremberg Code was set forth. Conscious of the violations of medical ethics before and during World War Two, the founders of the WMA immediately took steps to ensure that physicians would at least be aware of their ethical obligations. In 1954, after several years of study, the WMA adopted a set of Principles for Those in Research and Experimentation. This document was revised over the next ten years and eventually was adopted as the Declaration of Helsinki (DoH) in 1964. It was further revised in 1975, 1983, 1989, 1996, 2000 and 2008. The DoH is a concise summary of research ethics. Other, much more detailed, documents have been produced in recent years on research ethics in general (e.g., Council for International Organizations of Medical Sciences, International Ethical Guidelines for Biomedical Research Involving Human Subjects, 1993, revised in 2002) and on specific topics in research ethics (e.g., Nuffield Council on Bioethics [UK], The Ethics of Research Related to Healthcare in Developing Countries, 2002). Despite the different scope, length and authorship of these documents, they agree to a very large extent on the basic principles of research ethics. These principles have been incorporated in the laws and/or regulations of many countries and international organizations, including those that deal with the approval of drugs and medical devices.
Looking for the appropriate Israel Clinical Research Associates
The work of an Israel CRA or any Clinical Research Associate is to be the main communication link when it comes to an investigator and a sponsor.They deal with the process which need to do with certain clinical trials. They see to it that these trials are set up appropriately and monitored suitably up to the time that it becomes accomplished. It is crucial that a CRA knows his/her role especially during clinical trials for the reason that they are the ones who makes sure that everything goes according to schedule starting from the initiation process up to the point of progress of the study takes place.
Other than these main roles, Israel Clinical Research Associates also have other roles which consists of making sure that the entire process is safe for the human subjects and also having these coordinated with the ethics committee to make sure that every guidelines are followed suitably and there is authentication for every clinical study that has to be done. If there are any documents needed to be filed about any regulatory, a CRA ensures that everything is reported and accounted for.
If you are searching for the right associates to deal with in Israel, you?ll need to search for a Contact Research Organization that provides efficient and dependable professional support when it comes to conducting clinical trials. In relation to accomplishing much work for these clinical trials, there are medical device companies who are searching for professional help. Pharmaceutical companies and other medical institutions who wish to search for clinical trials done in Israel can take advantage of such services with the help of a company that is able of providing high quality services in this field.
On the other hand it is crucial to search for the right company that can take care of all of these, probably one that has the suitable experience and also an academic knowledge in doing such trials based on Israel. You might also consider such companies with partners with other professionals world-wide for expanded terms of service covering a wider perspective. To do this, you’ll have to perform some research online for solutions available for you to look into.
First Survey Made Public on the Understanding and Experiences of Clinical Research Volunteers in India
It is well known that India is a region of the world where clinical research is on the rise. There are many incentives for conducting research in India, including its huge population of treatment-naïve patients and lower cost of conducting trials. It’s estimated that by 2010, the clinical research market in India will reach 0-600 million (1) .
That growth has also brought a tremendous amount of regulatory oversight and safety measures to protect the rights of patients. But that growth has also attracted a tremendous amount of scrutiny and negative media coverage. However, not much information has been publicized regarding Indian patient’s knowledge and understanding of clinical research and their experiences, especially with the Informed Consent process.
Excel Life Sciences has recently conducted a survey of over 500 study participants. This Excel Life Sciences research brief analyzes the important findings of that study and includes comparisons to a study of U.S. patients conducted by CenterWatch.
Key Findings:
56% of patients in India were not aware of clinical research prior to participating in a study
97% of patients understood the informed consent form (70% very well, 27% well)
97% of patients first found out about the clinical study through a physician, vs just 23% in the United StatesOnly
8% of patients in India made the decision to participate on their own, vs 38% in the United States
Method: This research brief is comprised of proprietary data collected from the 2008 Informed Consent survey of Indian study volunteers by Excel Life Sciences and public data from a 2005/2006 U.S. patient survey conducted by CenterWatch and publicized at the 2006 DIA Annual Meeting. Excel Life Sciences collected the survey data through clinical research coordinators supporting studies at active clinical research sites. Data was collected from July 2008 and the survey is ongoing.
Observations and Conclusions:
Better than Expected Understanding
Considering that India is still an nascent market for clinical research, Excel Life Sciences was surprised to find that over 40% of patients had some understanding about clinical research trials prior to participating. Most patients though, lacked more than surface level awareness and understanding. Overall, patients seemed to have a strong understanding of what was required of them in a study and the risks of participating. In general, the vast majority of patients, some 97%, understood the informed consent document (70% very well, 27% somewhat well). Specifically, patients had a strong understanding of the following:
]]>
98% understood the number of times that they would have to visit the study site
93% understood that the study would carry risks and discomforts
Traditional Health Information Sources Used by Volunteers
The advent and expansion of the Internet, along with the litigious healthcare environment in the United States has caused many patients to pursue a variety of information sources to make educated healthcare decisions. In fact, U.S. surveys have found that more than 60% of volunteers go outside of their managed-care setting to self-refer into clinical trials. The Excel Life Sciences survey has found that there is a much more traditional information system in place in India, where patients still turn to their physicians for information about their health. In total 97% of patients in the Excel Life Sciences survey, first learned about the study through a physician, including primary care (76%) or another physician (21%).
Patients: Decision Support System is Strong
According to survey findings, there is both a cultural and operational support system in place in India assisting patients with making an informed decision:
Culturally, the role of the family and trust in their primary care physician play a very important part in a patient’s decision to participate. Most patients travel with loved ones to doctor visits and the same is true for their clinical trial visits. Only 8% of volunteers made the decision to participate in the trial by themselves vs. 38% in the United States.
Operationally, the sites involved in the survey had a dedicated highly trained clinical research coordinator working at the study site, assisting busy physicians with running the trial and helping to answer questions patients or their loved ones have about the study and informed consent form.
When considering this support system in India, it is interesting to note that Excel Life Sciences has found that average study retention rates are in the low to mid 90th percentile. In comparison, the United States and Western Europe historically see an average of 25% of trial volunteers drops out of trials before completion. Higher retention rates allow studies to finish sooner and help reduce study costs and speed the development of new compounds.
Authors:
Dr. Vijai Kumar, President and Chief Medical Officer – Excel Life Sciences,
Dr. Saurendra Das, Executive Director of Operations, India – Excel Life Sciences
Dan McDonald, Vice President-Business Strategy – Excel Life Sciences.
The study was last updated October 2008.
(1) Pricewaterhouse Coopers September 2008 Forecasting Report
About Excel Life Sciences
Headquartered in Chicago, IL with offices in Boston, Raleigh-Durham, Washington DC, Hyderabad, Mumbai, New Delhi and 21 other locations across India, ELS is one of the most experienced and fastest growing trial management and site support organizations in India, offering customized clinical trial solutions including: regulatory consulting, preparations, submissions and query resolution; site identification and selection; patient recruitment and retention; training of all clinical research stakeholders; technology transfer; product licensing and more.
ELS has one of the most experienced and respected clinical operations teams in India with over 125 years of collective experience in conducting more than 350 global and domestic trials at hundreds of sites and with thousands of patients. ELS has also trained over 1,500 clinical research personnel in India. For more information visit: www.excellifesciences.com
Clinical Trails – Phases For Public Safety
Clinical trials are tests conducted to find out the safety and efficacy of drugs before they are launched in the market. Clinical trials are conducted on a small group of people and analyzed to see if there are any adverse reactions to a particular drug. These trials also monitor the effectiveness of drugs.
There are different phases of clinical trials that are closely monitored by regulatory bodies. Almost all pharmaceutical companies and biotechnology firms utilize an efficient Clinical Trials Management System (CTMS) to manage the huge amount of data that clinical trials produce. A quality Clinical Trials Management System helps track, collate and analyze data during clinical trials.
]]>
Here are the three different phases of clinical trials:
Phase I:
First test of a new drug for treatment of a particular medical problem. The test is done because the drug has shown some promise of a cure in the laboratory. Tests are done to find out if the treatment is safe. What is the best mode of administration of the treatment? What is the right amount of dosage? The first phase is done on a very limited number of persons.
Phase II:
If the results of phase I suggest that the drug is safe, then the company moves towards the second phase of clinical trials. Here the drug is tested to see if it helps patients. Here the sample size is large and the treatment may be administered to over a hundred patients. Common side-effects of the drug is tracked and analyzed.
Phase III:
In Phase III, the new drug is usually compared to the existing treatment to see if it helps patients better. Studies are done to see if the new drug fares better or worse than the existing ones. Or whether the new drug produces the same results as the old one. The trials are conducted over a large section of patients with half the number of patients receiving the new drugs while the other half receives the old one. The efficacy of the new drug is then studied through comparison. This phase of clinical trials is generally more complex.
The development in Information Technology and the stringent regulations of regulatory authorities have increased the need for quality pharmacovigilance system. These systems help make clinical trials and other drug development processes so much easier and quicker.
Challenges in the Path of Clinical Supplies Process
Clinical trial constitutes an integral step in medical research that is carried out to collect data about the efficacy of a drug and to see whether it is safe for use. These trials can be carried out only after adequate information has been collected. Based on the kind of product and the current stage of development of the product, investigators appoint healthy volunteers or patients into groups, specifically for carrying out pilot studies. Therefore, clinical trials jobs revolve around determining the effectiveness and safety of a new drug or treatment. Clinical trials are becoming complicated these days and the testing often needs to be carried out within a limited time span.
Clinical trial supplies form the critical path bottleneck when it comes to availability and therefore affects the cycle time when it comes to making the product available in the market. A number of tools and practices can be used prior to the trial and during its different stages to make sure that the clinical supply chain is smooth and therefore can be managed more effectively.
]]>
There are different challenges that lie in the path of clinical supplies jobsin the different phases namely planning, manufacturing stage and final distribution. During the initial stages of the trials, a standard formula can be implemented to determine the necessary amount that can effectively be used on patients throughout the entire period of study.
A number of things can pose challenges during the planning stage itself. These include the duration of the clinical trials, the availability of patients and their recruitment. Proper clinical trials are dependent largely on the study supplies to different sites so that the drugs prescribed are administered at specific times.
The process of clinical supply manufacturing also faces numerous challenges. These include:
The necessity to develop small quantities of the product
The development of different dosage strengths, comparator products and placebos
Inadequate supply of API or active pharmaceutical ingredient
Limited expiration date due to the absence of long-term stability data
The distribution stage is also marked by its share of challenges. The shipment needs to be done in compliance with the state specific regulations and therefore distribution of the drug in different countries may pose numerous obstacles. These include:
GMP regulations and GCP or Good Clinical practices
An efficient and reliable accountability process in order to ensure that the drugs that are no longer in use can be destroyed, reconciled or returned
Proper tracking methods to check the various stages of drug development and monitor it to the end-to-end value chain
Investigator stock control for the sake of complete distribution planning
Ensuring that the resource material and information is shared amongst all partners
Making the inventory visible for the sake of distribution planning
A clinical trial protocol comprises a document that is used to acquire a confirmation of the trial design, which needs to be approved by a panel of experts. This is done in order to check that the clinical trial process has been carried out in adherence to the established protocol.
Advantages of clinical trails management system
Pharmaceutical and biotechnology companies spend thousands of dollars and a considerable amount of man hours on clinical trials of drugs before they are launched in the market. Clinical trial involves the use of humans to test the efficacy and hazards of a new drug.
Clinical trials are very elaborate procedures that are monitored by stringent regulations. The efficient management of clinical trials requires the use of a reliable Clinical Trial Management System that helps scientist monitor the clinical trials, analyze data, report to regulatory bodies and study the effectiveness and adverse effects of the drugs.
Clinical Trail Management System is a computerized system of data management which allows drug manufacturers to collect and organize data from clinical trials. With the Clinical Trial Management System, pharmaceutical firms can:
Collect, store and organize clinical data Assess the efficacy of drugs using stored data Research adverse effects using clinical data Monitor budgeting Handle patient management Verify compliance of trial procedures with government regulations Work simultaneously with other systems such as data management systems, electronic data capture, and adverse event reporting systems. Manage the manufacture and marketing of medicines after launch
Clinical Trial Management System is an indispensible tool to any pharmaceutical or biotechnology company. These systems help save on the time taken to organize and store data. Everyday is vital for a company, as there are thousands of patients waiting for a cure. Drug manufacturing is a very competitive industry; there are so many companies working on the same lines. The faster a pharmaceutical company comes out with a new cure, the sooner it can get the drug patented and the more income it can generate.
Clinical Trial Management Systems cuts down on administrative costs, helps access valuable data instantly and helps monitor compliance of trials to regulatory standards. Confidentiality is very important during trials. With a centralized access system, the data is kept secure. But most importantly, the system helps ensure the safety of drugs that are under trial.
Clinical Research Study Orange County
If you want to live on this beautiful planet for a long time and want to connoisseur the sweet air, the sweet fragrance of flowers, to flee in the open meadow like a deer you must have good health. It is a good health that has the prime importance. It is the Clinical Research Trials and Study Centre in Orange County taking this point into account wants to take the medical science to the apex of perfection.
Now if people are interested to take part in the trial they have to take firm decisions. There is a detailed questionnaire that may offer them the detailed information about the clinical trials. It offers them the elegance to talk to their dear and near ones about taking part in the trials.
It is known vide a protocol from the part of the Orange county Clinical Trials what type of people would be able to take part in the trial, what type of tests they would go through, the perfect medication, dosages and so on. In the grand clinical trial centre the participants are checked regularly by the research fellows to monitor the health of the participants and note down in details the efficacy of the treatment.
In the Orange county Clinical Trial Centre the scientists test a new medicine on twenty to eighty people just to assess the safety, the safe dose range, and the side effects related to the drug.
In the second phase the drug ready to be studied is given to about one hundred to three hundred people for further evaluation.
In the third phase the drug is given to about one thousand to three thousand people only to confirm the efficacy.
In the fourth phase the drug studies are made after the marketing of the drug.
The clinical trials in the US are governed by the institutional Review Board to observe if risks in the trials are low.
]]>
The Orange county clinical trial centre can boast of their study in different health conditions and different diseases. In the centre the interested person can go through tests for diseases related to immune deficiency such as AIDS. How AIDS can be combated well with the help of different medicines. Various therapies are followed to assess the trials.
Clinical Research Study Orange County always cares for the continuous improvement. The studies are randomly monitored by using a Question /Answer system. The persons associated with the trials are all qualified professionals and the staffs there are highly trained on research guidelines.
According to the Orange County Clinical Trial Centre, the demography there is such -
The percentage of Caucasian people in Orange County is about 51.
The Hispanic people are of 31 percent.
The number of the Asian people is 14%
The number of the African American is 1% and the other show a variety of only 3%.
The centre contains a database of about 10, 000 people who have already taken part in the clinical trials. It is known from different data that the Orange County comprises of the patients that hail solely from the Caucasian tree. Besides, the Trial Centre has free access to the other minority classes.
Attaining Clinical Specialist Training
Attaining clinical specialist training requires dedication and commitment. A clinical specialist is a highly trained nurse with specialization in a domain. Examples of specialization domains are patient, nursing personnel, and (healthcare) system. Specialty areas are illnesses and diseases, populations of patients (for example patients who suffer from traumatic brain injury), type of care, or type of problem. Clinical specialist training typically spans six years, post high school. However, at the completion of your studies, you will enjoy an in-demand career with plentiful job openings, in a variety of health care settings.
The first step towards acquiring clinical specialist training is to earn a bachelor’s degree in nursing, commonly referred to as a BSN. A bachelor’s degree typically takes four to four and one half years to complete. In addition to attending classes, nursing students engage in fieldwork experiences with actual patients, as part of their program of study.
]]>
After earning your bachelor’s degree in nursing, you must enroll in an accredited graduate level nursing program. A master of science degree in nursing, commonly referred to as an MSN, will provide the expertise required for the specialization. Specifically, the program teaches assessment techniques, patient care, and outcome evaluation. You will gain expertise in training nurses in clinical competencies, educating patients and their families, and collaborating with an interdepartmental team of other allied health care professionals. The program will teach you how to plan and implement alternative procedures, engaging in medical research, and overseeing patient care. Upon completion of your master’s degree, you will take a proficiency exam from your state’s board of nursing to earn licensure.
Nursing is a demanding but highly rewarding profession. Regardless of the state of the economy, nurses are constantly in demand, at a wide array of health care settings. Clinical specialist training will expand your career far beyond direct care.